Leveraging the Microbiome to Break Down Tumor Resistance
Webinar

Leveraging the Microbiome to Break Down Tumor Resistance

Mat Robinson and Mark Tangney discuss how enhancing the efficacy of immune checkpoint inhibitors improves patient outcomes.

Share

This webinar will be hosted live and available on-demand

 Thursday, September 15th, 2022 
11:00 AM - 12:30 PM Eastern Time (8:00 AM PDT / 4:00 PM GMT)

Immunotherapies, such as immune checkpoint inhibitors, have been a game changer in treating cancer patients. However, despite significant treatment advances, many patients fail to respond therapy. Researchers are exploring factors that influence individual differences in treatment response to predict which patients will respond to immunotherapy. The gut microbiome has emerged as an important immune response modulator and scientists can leverage this community to overcome tumor resistance to immune checkpoint inhibitors.

In this webinar brought to you by PerkinElmer, Mat Robinson and Mark Tangney will explore the emerging role of microbiome precision medicine in immuno-oncology, including the use of fecal microbiota transplantation as a novel adjuvant to immune checkpoint therapy in cancer patients.

Topics to be covered

  • How the immune response is linked to gut microbiome composition
  • Why fecal transplants enhance immune checkpoint treatment efficacy
  • How microbiome signatures provide a predictive biomarker to stratify patient responders to checkpoint therapy


Mat Robinson, PhD
Vice President, Translational Biology
Microbiotica Limited

Mark Tangney, PhD
Principle Investigator
University College Cork

Top Image Credit:

3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio